Cingulate (CINGW) Expected to Announce Quarterly Earnings on Wednesday

Cingulate (NASDAQ:CINGW) is expected to be issuing its resultson Wednesday, May 13th. Analysts expect the company to announce earnings of ($0.52) per share for the quarter.

Cingulate Stock Performance

Shares of NASDAQ:CINGW opened at $0.02 on Wednesday. The company has a fifty day simple moving average of $0.03 and a 200 day simple moving average of $0.05. Cingulate has a 12-month low of $0.02 and a 12-month high of $0.18.

About Cingulate

Cingulate Inc, a biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of attention deficit/hyperactivity disorder and anxiety in the United States. The company’s stimulant medications are CTx-1301 (dexmethylphenidate), which is in phase 3 clinical trial, as well as CTx-1302 (dextroamphetamine), which is in investigational new drug application development for the treatment of attention deficit/hyperactivity disorder intended for children, adolescents, and adults.